Zhang Y, Shi W, Tang S, Li J, Yin S, Gao X, Wang L, Zou L, Zhao J, Huang Y, Shan L, Gounni AS, Wu Y, Yuan F, Zhang J: The influence of cathelicidin LL37 in human anti-neutrophils cytoplasmic antibody (ANCA)-associated vasculitis. Arthritis Res Ther. 2013, 15: R161-10.1186/ar4344.
Article
PubMed
PubMed Central
Google Scholar
Heilborn JD, Nilsson MF, Chamorro Jimenez CI, Sandstedt B, Borregaard N, Tham E, Sørensen OE, Weber G, Ståhle M: Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells. Int J Cancer. 2005, 114: 713-719. 10.1002/ijc.20795.
Article
CAS
PubMed
Google Scholar
Kittaka M, Shiba H, Kajiya M, Ouhara K, Takeda K, Kanbara K, Fujita T, Kawaguchi H, Komatsuzawa H, Kurihara H: Antimicrobial peptide LL37 promotes vascular endothelial growth factor-a expression in human periodontal ligament cells. J Periodontal Res. 2013, 48: 228-234. 10.1111/j.1600-0765.2012.01524.x.
Article
CAS
PubMed
Google Scholar
Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CGM, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DGI, Specks U, Stone JH, Takahashi K, Watts RA: Revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2012, 2013: 1-11.
Google Scholar
Jennette JC, Falk RJ, Gasim AH: Pathogenesis of antineutrophil cytoplasmic autoantibody vasculitis. Curr Opin Nephrol Hypertens. 2011, 20: 263-270. 10.1097/MNH.0b013e3283456731.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jennette JC, Xiao H, Falk R, Gasim AM: Experimental models of vasculitis and glomerulonephritis induced by antineutrophil cytoplasmic autoantibodies. Contrib Nephrol. 2011, 169: 211-220.
Article
CAS
PubMed
Google Scholar
Dombrowski Y, Schauber J: Cathelicidin LL-37: a defense molecule with a potential role in psoriasis pathogenesis. Exp Dermatol. 2012, 21: 327-330. 10.1111/j.1600-0625.2012.01459.x.
Article
CAS
PubMed
Google Scholar
Wong JH, Legowska A, Rolka K, Ng TB, Hui M, Cho CH, Lam WW, Au SW, Gu OW, Wan DC: Effects of cathelicidin and its fragments on three key enzymes of HIV-1. Peptides. 2011, 32: 1117-1122. 10.1016/j.peptides.2011.04.017.
Article
CAS
PubMed
Google Scholar
Iacob SA, Panaitescu E, Iacob DG, Cojocaru M: The human cathelicidin LL37 peptide has high plasma levels in B and C hepatitis related to viral activity but not to 25-hydroxyvitamin D plasma level. Rom J Intern Med. 2012, 50: 217-223.
CAS
PubMed
Google Scholar
Doss M, White MR, Tecle T, Hartshorn KL: Human defensins and LL-37 in mucosal immunity. J Leukocyte Biol. 2010, 87: 79-92. 10.1189/jlb.0609382.
Article
CAS
PubMed
Google Scholar
Gilla K, Mohantib BK, Singha AK, Mishraa B, Deya S: The over expression of cathelicidin peptide LL37 in head and neck squamous cell carcinoma: the peptide marker for the prognosis of cancer. Cancer Biomarkers. 2012, 10: 125-134.
Google Scholar
Jann NJ, Schmaler M, Kristian SA, Radek KA, Gallo RL, Nizet V, Peschel A, Landmann R: Neutrophil antimicrobial defense against Staphylococcus aureus is mediated by phagolysosomal but not extracellular trap-associated cathelicidin. J Leukoc Biol. 2009, 86: 1159-1169. 10.1189/jlb.0209053.
Article
CAS
PubMed
PubMed Central
Google Scholar
Van Avondt K, Fritsch-Stork R, Derksen RH, Meyaard L: Ligation of signal inhibitory receptor on leukocytes-1 suppresses the release of neutrophil extracellular traps in systemic lupus erythematosus. PLoS One. 2013, 8: e78459-10.1371/journal.pone.0078459.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kessenbrock K, Krumbholz M, Schönermarck U, Back W, Gross WL, Werb Z, Gröne HJ, Brinkmann V, Jenne DE: Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med. 2009, 15: 623-625. 10.1038/nm.1959.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kaplan-Pavlovcic S, Cerk K, Kveder R, Lindic J, Vizjak A: Clinical prognostic factors of renal outcome in anti-neutrophil cytoplasmic autoantibody (ANCA)-associated glomerulonephritis in elderly patients. Nephrol Dial Transplant. 2003, 18: v5-v7. 10.1093/ndt/gfg1033.
Article
PubMed
Google Scholar
Slot MC, Tervaert JW, Franssen CF, Stegeman CA: Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney Int. 2003, 63: 670-677. 10.1046/j.1523-1755.2003.00769.x.
Article
PubMed
Google Scholar
Lionaki S, Blyth ER, Hogan SL, Hu Y, Senior BA, Jennette CE, Nachman PH, Jennette JC, Falk RJ: Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum. 2012, 64: 3452-3462. 10.1002/art.34562.
Article
CAS
PubMed
PubMed Central
Google Scholar
Specks U: Controversies in ANCA testing. Cleve Clin J Med. 2012, 79: S7-S11. 10.3949/ccjm.79.s3.02.
Article
PubMed
Google Scholar
Roth AJ, Ooi JD, Hess JJ, van Timmeren MM, Berg EA, Poulton CE, McGregor J, Burkart M, Hogan SL, Hu Y, Winnik W, Nachman PH, Stegeman CA, Niles J, Heeringa P, Kitching AR, Holdsworth S, Jennette JC, Preston GA, Falk RJ: Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis. J Clin Invest. 2013, 123: 1773-1783. 10.1172/JCI65292.
Article
CAS
PubMed
PubMed Central
Google Scholar
Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC, Joh K, Neumann I, Noël LH, Pusey CD, Waldherr R, Bruijn JA, Bajema IM: Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010, 21: 1628-1636. 10.1681/ASN.2010050477.
Article
PubMed
Google Scholar
Ford SL, Polkinghorne KR, Longano A, Dowling J, Dayan S, Kerr PG, Holdsworth SR, Kitching AR, Summers SA: Histopathologic and clinical predictors of kidney outcomes in ANCA-associated vasculitis. Am J Kidney Dis. 2014, 63: 227-235. 10.1053/j.ajkd.2013.08.025.
Article
PubMed
Google Scholar